Login / Signup

Can we overcome the heterogeneity of mood disorders in clinical trials?

Aswin RatheeshMichael BerkLianne Schmaal
Published in: The Australian and New Zealand journal of psychiatry (2023)
Keyphrases
  • clinical trial
  • bipolar disorder
  • single cell
  • sleep quality
  • phase ii
  • open label
  • phase iii